Veterinary Medicine Is Fastest Growing Segment Fueling The Growth Of The Global Enrofloxacin Market

Enrofloxacin Market


The global Enrofloxacin Market is estimated to be valued at US$ 470.4 Mn in 2023 and is expected to exhibit a CAGR of 4.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market Overview:


Enrofloxacin is an antibacterial medicine used in veterinary medicine to treat bacterial infections in animals. It functions by disrupting the DNA replication of bacteria and inhibiting the bacterial reproduction. It is commonly used to treat respiratory infections, skin infections, and urinary tract infections in animals.


Market key trends:


One of the key trends fueling the growth of the enrofloxacin market is the rising animal healthcare expenditure globally. For instance, according to the American Pet Products Association (APPA), the total U.S. pet industry expenditures in 2021 amounted to over $110 billion, out of which over $30 billion was spent on veterinary care. Furthermore, increasing prevalence of zoonotic diseases is necessitating strong animal healthcare protocols, thereby driving the demand for veterinary medicines such as enrofloxacin. Additionally, growing consumption of animal-based food products is also boosting the adoption of improved animal healthcare practices to avoid losses due to mortality and improve productivity, thus propelling the enrofloxacin market growth.

Segment Analysis


The global enrofloxacin market is segmented into livestock, poultry, and companion animals. The poultry segment dominated the market in 2022 and is expected to continue its dominance during the forecast period. Poultry farming is one of the major applications of enrofloxacin as poultry diseases are widespread which requires preventive medication. Enrofloxacin is mainly used to treat respiratory diseases in poultry.


Key Takeaways


The Global Enrofloxacin Market Demand size was valued at US$ 470.4 Mn in 2023. It is expected to grow at a CAGR of 4.1% during 2023-2030.

Regional Analysis
North America dominated the global enrofloxacin market in 2022 owing to advancements in animal husbandry practices and increasing investments in animal health. The Asia Pacific region is expected to witness the fastest growth over the forecast period due to rising meat consumption and increasing awareness about animal diseases in emerging economies like India and China.

Key Players
Key players operating in the enrofloxacin market are Bayer AG, Zoetis Inc., Boehringer Ingelheim GmbH, Merck & Co., Inc., Virbac S.A., Ceva Santé Animale, Elanco Animal Health, Bimeda, Aurobindo Pharma Limited, and Teva Pharmaceutical Industries Ltd. Bayer AG is one of the leading players due to its strong portfolio of enrofloxacin products and global presence across key markets.

 

For more insights, read- https://www.marketwebjournal.com/enrofloxacin-market-growth-and-trnds-analysis-share-size-demand-forecast/ 

 

Comments

Popular posts from this blog

Navigating Opportunities In The Niemann-Pick Disease Drug Type C Treatment Market

Idiopathic Hypersomnia Treatment Market is Anticipated to Witness High Growth Owing to Increasing Prevalence of Idiopathic Hypersomnia

Riding the Wave: Navigating Dynamics in the Windsurf Foil Board Market